---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-009587"
form_type: "8-K"
ticker: "ETON"
cik: "0001710340"
company_name: "Eton Pharmaceuticals, Inc."
filed_at: "2022-04-11T23:59:59+00:00"
generated_at: "2026-06-26T08:15:43.044934+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Eton Pharmaceuticals appoints James Gruber as CFO; Wilson Troutman retires

## Summary
- James Gruber appointed CFO, Treasurer, Secretary effective April 11, 2022.
- Gruber previously U.S. Controller at Horizon Therapeutics for 7 years.
- Wilson Troutman retired as CFO, will assist transition through May 31, 2022.
- Gruber receives $350K base salary, 40% target bonus, option for 100,000 shares vesting over 4 years.
- Company owns or receives royalties from six FDA-approved products, four more submitted.

## SEC filing metadata
- accession: 0001493152-22-009587
- form_type: 8-K
- ticker: ETON
- cik: 0001710340
- company_name: Eton Pharmaceuticals, Inc.
- filed_at: 2022-04-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1710340/000149315222009587/0001493152-22-009587-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1710340/000149315222009587/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-009587
- JSON: https://secwatch.observer/filing/0001493152-22-009587.json
- Plain text: https://secwatch.observer/filing/0001493152-22-009587.txt

## Key facts
- Executive change
  Wilson Troutman retired as Chief Financial Officer, Corporate Secretary and Treasurer at Eton Pharmaceuticals, Inc..
  - Action: retired
  - Role: Chief Financial Officer, Corporate Secretary and Treasurer
  source text: Mr. Gruber succeeds Wilson Troutman, who retired as Chief Financial Officer, Corporate Secretary and Treasurer of the Company effective April 11, 2022 as well.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1710340/000149315222009587/0001493152-22-009587-index.htm
- Executive change
  James Gruber was appointed as Chief Financial Officer, Corporate Secretary and Treasurer at Eton Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Chief Financial Officer, Corporate Secretary and Treasurer
  source text: Effective April 11, 2022 the Board of Directors (the “Board”) of Eton Pharmaceuticals, Inc. (the “Company”) appointed James Gruber to serve as the Company’s Chief Financial Officer, Corporate Secretary and Treasurer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1710340/000149315222009587/0001493152-22-009587-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.